Adverum Biotechnologies Inc banner

Adverum Biotechnologies Inc
F:AVU

Watchlist Manager
Adverum Biotechnologies Inc Logo
Adverum Biotechnologies Inc
F:AVU
Watchlist
Price: 14.8 EUR
Market Cap: €3.1B

Wall St Price Targets

AVU Price Targets Summary
Adverum Biotechnologies Inc

There are no price targets for AVU.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Adverum Biotechnologies Inc Competitors:
Price Targets
3363
FOCI Fiber Optic Communications Inc
12% Upside
SDGR
Schrodinger Inc
11% Upside
FAST
Fastenal Co
-5% Downside

Revenue
Forecast

7% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 7%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AVU's stock price target?
Not Available

AVU does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett